ストックスクリーナーアプリを入手
189.60
2.38%
-4.62
前日終値:
$194.22
開ける：
$194.57
24時間の取引高:
3.16M
Relative Volume:
1.29
時価総額：
$40.08B
収益：
$398.11M
当期純損益:
$-1.03B
株価収益率:
-33.24
EPS:
-5.7032
ネットキャッシュフロー:
$-868.57M
1週間 パフォーマンス:
+18.75%
1か月 パフォーマンス:
+31.66%
6か月 パフォーマンス:
+163.33%
1年 パフォーマンス:
+181.81%
1日の値動き範囲:
$187.02
$197.08
1週間の範囲:
$160.53
$197.08
52週間の値動き範囲:
$60.40
$197.08
Insmed Inc Stock (INSM) Company Profile
INSM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-28 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-10-20 | 開始されました | Wells Fargo | Overweight |
| 2025-08-20 | 開始されました | William Blair | Outperform |
| 2025-08-13 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 開始されました | Jefferies | Buy |
| 2025-02-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-04-23 | 開始されました | Truist | Buy |
| 2024-02-15 | 開始されました | Wolfe Research | Outperform |
| 2023-12-08 | 開始されました | Wells Fargo | Overweight |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-07-26 | 開始されました | Guggenheim | Buy |
| 2022-12-09 | 開始されました | Mizuho | Buy |
| 2022-12-07 | 開始されました | Barclays | Overweight |
| 2022-11-18 | 開始されました | BofA Securities | Buy |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2021-12-06 | 開始されました | JP Morgan | Overweight |
| 2021-10-19 | 再開されました | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-12-17 | 開始されました | Berenberg | Buy |
| 2020-10-12 | 再開されました | Stifel | Buy |
| 2019-09-03 | 開始されました | Goldman | Buy |
| 2019-04-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-02-15 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | アップグレード | Goldman | Neutral → Buy |
| 2019-01-02 | 開始されました | Canaccord Genuity | Buy |
| 2018-08-06 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 開始されました | Goldman | Neutral |
| 2018-04-23 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 開始されました | Morgan Stanley | Overweight |
| 2018-01-18 | 開始されました | Credit Suisse | Neutral |
| 2017-09-05 | 繰り返されました | Evercore ISI | Outperform |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-07-11 | 開始されました | Robert W. Baird | Outperform |
| 2016-03-15 | 開始されました | Stifel | Buy |
| 2015-11-09 | ダウングレード | UBS | Buy → Neutral |
| 2015-10-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-06-09 | 開始されました | Citigroup | Neutral |
| 2014-03-26 | 繰り返されました | HC Wainwright | Buy |
すべてを表示
Insmed Inc (INSM) 最新ニュース
Historical volatility pattern of Insmed Incorporated visualizedPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Insmed (NASDAQ:INSM) Posts Earnings Results, Misses Estimates By $0.40 EPS - MarketBeat
Wells Fargo Raises Price Target for INSM to $217, Maintains Over - GuruFocus
Insmed (NASDAQ:INSM) Hits New 12-Month HighTime to Buy? - MarketBeat
Goldman Sachs Boosts Insmed (INSM) Price Target to $225 | INSM S - GuruFocus
INSM: UBS Maintains 'Buy', Raises Price Target to $223 | INSM St - GuruFocus
Insmed Shares Likely to Gain From Brinsupri Sales, Untapped Pipeline, UBS Says - MarketScreener
Insmed stock surges as UBS raises price target on Brinsupri launch success - Investing.com Canada
Insmed (INSM) Sees Price Target Raised by RBC Capital to $215 | - GuruFocus
Insmed (INSM) Hits All-Time High as Firm Posts Highly Optimistic Outlook - Insider Monkey
Insmed Q3 2025 slides reveal strong BRINSUPRI debut, ARIKAYCE growth accelerates - Investing.com Australia
Insmed stock hits 52-week high at 170.3 USD By Investing.com - Investing.com Australia
RBC Raises Price Target on Insmed to $215 From $139, Keeps Outperform Rating - MarketScreener
Insmed Misses on Q3 Earnings, Stock Rises on Strong Brinsupri Uptake - TradingView
Cantor Fitzgerald Comments on Insmed FY2025 Earnings - MarketBeat
UBS Adjusts Insmed Price Target to $223 From $194, Maintains Buy Rating - MarketScreener
Truist Raises Price Target on Insmed to $214 From $139, Keeps Buy Rating - MarketScreener
Insmed: Q3 Earnings Snapshot - Stamford Advocate
Emerald Mutual Fund Advisers Trust Sells 328,407 Shares of Insmed, Inc. $INSM - MarketBeat
Emerald Advisers LLC Decreases Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed Reaches Analyst Target Price - Nasdaq
How Insmed Incorporated stock reacts to Fed rate cutsFed Meeting & Risk Managed Investment Entry Signals - newser.com
Insmed, Inc. $INSM Shares Sold by Jennison Associates LLC - MarketBeat
What machine learning models say about Insmed IncorporatedJuly 2025 PreEarnings & AI Enhanced Trade Execution Alerts - newser.com
Is Insmed Incorporated (IM8N) stock among top earnings playsPortfolio Gains Summary & AI Optimized Trading Strategy Guides - newser.com
Biotech Stocks Hit 52-Week Highs: MTSR, INSM, ABVX, MAZE Lead October 30 Surge - RTTNews
Why Insmed Incorporated is moving today2025 Fundamental Recap & Free Community Consensus Stock Picks - newser.com
Insmed Q3 2025 Earnings Call Transcript - MarketBeat
Insmed earnings missed by $0.41, revenue topped estimates - Investing.com Canada
Will Insmed Incorporated (IM8N) stock see valuation expansionEarnings Growth Report & Free Fast Gain Swing Trade Alerts - newser.com
Will Insmed Incorporated stock outperform Dow Jones indexJuly 2025 Update & Real-Time Chart Pattern Alerts - newser.com
A Look at Insmed (INSM) Valuation Following EU Brensocatib Milestone and ARIKAYCE Revenue Upgrade - Yahoo Finance
Decoding Insmed Inc (INSM): A Strategic SWOT Insight - GuruFocus
Insmed stock price target raised to $223 by TD Cowen on strong Brinsupri launch - Investing.com Nigeria
Insmed Incorporated (INSM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Insmed Inc (INSM) Q3 2025 Earnings Call Highlights: Strong Launch for Brin Suri and Robust ... By GuruFocus - Investing.com Canada
Insmed Incorporated (INSM) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
INSM: On the Rise Again or Just a Bubble? - StocksToTrade
Insmed Inc (INSM) Q3 2025 Earnings Call Highlights: Strong Launch for Brin Suri and Robust ... - Yahoo! Finance UK
Insmed price target raised to $196 from $165 at Mizuho - MSN
Insmed Incorporated Raises Global ARIKAYCE Revenue Guidance for the Full Year 2025 - MarketScreener
Insmed Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Insmed Reports Strong Sales Growth And Raises Guidance For 2025 - Finimize
Insmed’s Promising Future: Are Gains Imminent? - StocksToTrade
Insmed Incorporated 2025 Q3ResultsEarnings Call Presentation (NASDAQ:INSM) 2025-10-30 - Seeking Alpha
Insmed’s Strong Financial Performance and Promising Product Launches Reinforce Buy Rating - TipRanks
Earnings call transcript: Insmed Q3 2025 sees revenue beat, stock surges - Investing.com
Insmed (INSM) 2025 Revenue Projections Reach $473.05 Million - GuruFocus
Oct 30 (Reuters)Insmed Q3 EPS USD -1.75. - 富途牛牛
Insmed (INSM) Price Target Increased by 13.59% to 178.15 - MSN
Insmed (INSM) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
Insmed Inc (INSM) 財務データ
収益
当期純利益
現金流量
EPS
0.73%
0.23%
大文字化:
|
ボリューム (24 時間):